News
Novo Nordisk finds Ozempic effective in lowering blood sugar
Publishing the results in The Lancet Diabetes & Endocrinology, Novo Nordisk has indicated that a trial met its primary endpoint, with Ozempic (semaglutide) injection 1.0 mg demonstrating a statistically significant and superior reduction in HbA1c.
Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology
Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects - Marks company's 13th CRISPR patent overall - Actively licensing CRISPR-related patents to interested parties
Roche presents data from Biognosys for use of discovery proteomics in clinical trials
A study by Roche suggests that discovery proteomics might soon move into the clinical trial setting, in a recent mock study using Biognosys’ DIA LC-MS/MS data, which mimics the implementation of discovery proteomics in a clinical investigation framework.
BIRAC announces vacancy in the Secretariat of Scientific Sub – Committee under the National Technical Board on Nutrition
Applications are invited from qualified and experienced professionals for various positions in the Secretariat of the Scientific Sub – Committee under the National Technical Board on Nutrition at BIRAC.
Exhibit in the 'India Pavilion' at BIO 2026
